Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Inhalable Drugs Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of respiratory diseases such as chronic obstructive pulmonary diseases and asthma
5.1.1.2. Increasing healthcare infrastructure and rising awareness among patients
5.1.1.3. Surge in the number of non-respiratory diseases such as Parkinson’s disease
5.1.2. Restraints
5.1.2.1. Strict regulations for the approval of inhalable drugs
5.1.3. Opportunities
5.1.3.1. Surge in development of inhalable drugs for ease of administration
5.1.3.2. Emerging reformulation of current non-inhaled molecules into inhaled molecules for improved drug delivery
5.1.4. Challenges
5.1.4.1. Availability of unregulated and alternate therapy
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Inhalable Drugs Market, by Product
6.1. Introduction
6.2. Aerosol
6.3. Dry Powder Formulation
6.4. Spray

7. Inhalable Drugs Market, by Application
7.1. Introduction
7.2. Non-Respiratory Diseases
7.3. Respiratory Diseases

8. Americas Inhalable Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Inhalable Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Inhalable Drugs Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Aptargroup, Inc.
12.1.2. AstraZeneca PLC
12.1.3. Avalyn Pharma, Inc.
12.1.4. Boehringer Ingelheim International GmbH
12.1.5. Cipla Inc.
12.1.6. GEA Group Aktiengesellschaft
12.1.7. Merck & Co., Inc.
12.1.8. Novartis AG
12.1.9. Orion Corporation
12.1.10. Pfizer Inc.
12.1.11. PureIMS B.V.
12.1.12. Respira Therapeutics Inc.
12.1.13. Sanofi S.A.
12.1.14. Sunovion Pharmaceuticals Inc. by Sumitomo Dainippon Pharma Co., Ltd.
12.1.15. Teva Pharmaceutical Industries Ltd.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. INHALABLE DRUGS MARKET RESEARCH PROCESS
FIGURE 2. INHALABLE DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. INHALABLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. INHALABLE DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. INHALABLE DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INHALABLE DRUGS MARKET DYNAMICS
FIGURE 7. INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS INHALABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS INHALABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES INHALABLE DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES INHALABLE DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC INHALABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC INHALABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INHALABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INHALABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. INHALABLE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. INHALABLE DRUGS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. INHALABLE DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. INHALABLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INHALABLE DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. INHALABLE DRUGS MARKET SIZE, BY AEROSOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. INHALABLE DRUGS MARKET SIZE, BY DRY POWDER FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. INHALABLE DRUGS MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 10. INHALABLE DRUGS MARKET SIZE, BY NON-RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. INHALABLE DRUGS MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. AMERICAS INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS INHALABLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. BRAZIL INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. CANADA INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 20. CANADA INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. MEXICO INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. MEXICO INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES INHALABLE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. ASIA-PACIFIC INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC INHALABLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. AUSTRALIA INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. CHINA INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. CHINA INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. INDIA INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. INDIA INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. INDONESIA INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. JAPAN INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. JAPAN INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. MALAYSIA INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. PHILIPPINES INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. SINGAPORE INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. SOUTH KOREA INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. TAIWAN INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. THAILAND INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. THAILAND INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. VIETNAM INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA INHALABLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. DENMARK INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. DENMARK INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. EGYPT INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. EGYPT INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. FINLAND INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. FINLAND INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. FRANCE INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. FRANCE INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. GERMANY INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. GERMANY INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. ISRAEL INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. ITALY INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. ITALY INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. NETHERLANDS INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. NIGERIA INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. NORWAY INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. NORWAY INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. POLAND INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. POLAND INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. QATAR INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. QATAR INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SOUTH AFRICA INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SPAIN INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. SPAIN INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SWEDEN INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SWITZERLAND INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. TURKEY INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. TURKEY INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM INHALABLE DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM INHALABLE DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. INHALABLE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 99. INHALABLE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 100. INHALABLE DRUGS MARKET LICENSE & PRICING